Skip to content
DataLookout
Menu

CLAARITYNCT07742839

CLAARITY is a Prospective, Observational, Single-arm, Multi-center, Post-market US Study Designed to Evaluate the Safety and Performance of the ECLIPTIS Left Atrial Appendage Exclusion System for Exclusion of the Left Atrial Appendage (LAA) During Concomitant Open-heart Cardiac Surgery.

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Start date: Sep 30, 2026 to Nov 30, 2026
    • Eligibility criteria expanded, about 10 words
    • Primary endpoints: details revised at 1 of 2 entries
    • Secondary endpoints: details revised at 1 of 2 entries
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Percentage of participants who have device technical success
Timeframe: Intra-operative
Participant's rate of major clinically significant adverse events
Timeframe: 30 days

Secondary (2)

Percentage of participants who have device technical success
Participant's rate of major clinically significant adverse events over time

Arms and interventions

Edwards ECLIPTIS Left Atrial Appendage Exclusion System

Subjects who were treated with the ECLIPTIS Left Atrial Appendage Exclusion System

Devices: Edwards ECLIPTIS Left Atrial Appendage Exclusion System